Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis
- PMID: 16315280
- DOI: 10.1002/ana.20743
Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis
Abstract
Despite many years of intensive research, multiple sclerosis (MS) defies understanding and treatment remains suboptimal. The prevailing hypothesis is that MS is immune mediated and that experimental allergic encephalomyelitis (EAE) is a suitable model to elucidate pathogenesis and devise therapy. This review examines critically the validity that EAE is an adequate and useful animal model of MS and finds credible evidence lacking. EAE represents more a model of acute central nervous system inflammation than the counterpart of MS. We propose to reconsider the utilization of EAE, especially when this model is used to define therapy. This will also force us to examine MS without the restraints imposed by EAE, as to what it is, rather than what it looks like.
Comment in
-
How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis.Ann Neurol. 2006 Jul;60(1):12-21. doi: 10.1002/ana.20913. Ann Neurol. 2006. PMID: 16802293 Review.
Similar articles
-
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.Crit Rev Clin Lab Sci. 1995;32(2):121-82. doi: 10.3109/10408369509084683. Crit Rev Clin Lab Sci. 1995. PMID: 7598789 Review.
-
The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis.Neurol Clin. 1995 Feb;13(1):51-73. Neurol Clin. 1995. PMID: 7739505 Review.
-
Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.J Neurol Sci. 2005 Jun 15;233(1-2):61-5. doi: 10.1016/j.jns.2005.03.005. Epub 2005 Apr 22. J Neurol Sci. 2005. PMID: 15949496 Review.
-
Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.Neuroimmunomodulation. 2008;15(1):76-83. doi: 10.1159/000135627. Epub 2008 Jul 29. Neuroimmunomodulation. 2008. PMID: 18667803
-
Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis.Neuropharmacology. 2010 Sep;59(3):180-9. doi: 10.1016/j.neuropharm.2010.05.005. Epub 2010 May 21. Neuropharmacology. 2010. PMID: 20493888
Cited by
-
CD8 T-cell Recruitment Into the Central Nervous System of Cuprizone-Fed Mice: Relevance to Modeling the Etiology of Multiple Sclerosis.Front Cell Neurosci. 2020 Mar 10;14:43. doi: 10.3389/fncel.2020.00043. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32210765 Free PMC article.
-
Induction of experimental autoimmune encephalomyelitis with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant in three non-human primate species.J Neuroimmune Pharmacol. 2013 Dec;8(5):1251-64. doi: 10.1007/s11481-013-9487-z. Epub 2013 Jul 3. J Neuroimmune Pharmacol. 2013. PMID: 23821341 Free PMC article.
-
Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus.Prog Neurobiol. 2013 Feb-Mar;101-102:46-64. doi: 10.1016/j.pneurobio.2012.11.003. Epub 2012 Nov 29. Prog Neurobiol. 2013. PMID: 23201558 Free PMC article.
-
Current concepts in multiple sclerosis: autoimmunity versus oligodendrogliopathy.Clin Rev Allergy Immunol. 2012 Feb;42(1):26-34. doi: 10.1007/s12016-011-8287-6. Clin Rev Allergy Immunol. 2012. PMID: 22189514 Review.
-
Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis.J Neuroinflammation. 2006 Sep 11;3:26. doi: 10.1186/1742-2094-3-26. J Neuroinflammation. 2006. PMID: 16965627 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical